GoingToMeet

The Emerging Strategies in Breast Cancer: Targeting Tomorrow’s Therapies Today 1-day conference will address emerging treatments for patients with breast cancer, with an emphasis on new pathways and novel agents in both early and later stages of clinical development. The goal of this conference is to provide oncologists and academic researchers with an overview of current knowledge regarding the biologic mechanisms underlying the development and progression of breast cancer as well as molecular tools in development for the individualization of therapy based upon unique tumor characteristics. Controversial and emerging topics will be addressed, including new approaches to endocrine therapy and chemotherapy, the evolving role of HER2-targeted agents and angiogenesis inhibitors, current and future uses of breast cancer genotyping, and the optimal treatment of metastatic breast cancer. The conference will also focus on new agents in clinical development that will have an impact on the natural history of breast cancer.